The Yinfeng Life Continuation Plan Documentary "China Temperature" Rated as an Excellent Case of Brand Building in 2024
Release time:
2024-12-24
On December 19th, the "2024 Shandong Brand Annual Conference and ESG Construction and Brand Value Enhancement Forum" was grandly held in Jinan, Shandong. The event was hosted by the Shandong Brand Development Promotion Association and Phoenix Net Shandong Channel, gathering over 300 representatives from provincial government agencies, brand enterprises, industry associations, social organizations, higher education institutions, research institutes, and mainstream media. The Shandong Yinfeng Life Science Research Institute (henceforth referred to as Yinfeng Life Science Institute) was invited to participate.
Brands are an important symbol of high-quality development. Under the drive of strategies such as Brand Strong Province and Good Products Shandong, Shandong brands have risen to prominence. Particularly in recent years, Shandong brands have focused on new quality productivity, using "new" to enhance quality, achieving remarkable results in high-quality development.

At the conference, the Shandong Brand Development Promotion Association announced the results of the 2024 evaluations for "Outstanding Members," "Outstanding Brand Workers," "Excellent Brand Building Cases," and "ESG Excellent Cases." The Yinfeng Life Science Institute's Life Continuation Plan documentary "China Temperature" was rated as an excellent case of brand building for 2024. Previously, this film also received a national award in the "International Communication Competition for Telling China's Stories" organized by the China Foreign Languages Publishing Administration.
As a bright emblem of scientific and technological innovation in Shandong, the Yinfeng Life Continuation Plan has again gained recognition and understanding from more people. In the future, Yinfeng Life Science Institute will continue to commit to research in the fields of cryogenic biomedicine and life sciences, leveraging this conference as an opportunity to thrive and contribute to the brilliant achievements of Shandong's brand-building efforts, promoting the splendor of Chinese brands on the global stage.
Latest developments
The debut and discourse of the YinFeng Life Continuation Project not only served as an authoritative demonstration of its own ethical governance framework but also contributed practical wisdom toward establishing industry norms.
Yinfeng Foundation Honored as "2025 Public Welfare Donor" by Jinan Red Cross
Looking ahead, Yinfeng Foundation will use this recognition as an opportunity to further deepen its strategic collaboration with the Jinan Red Cross, expand cooperation in areas such as life health and emergency response, and continue to empower efforts to accelerate the construction of a "new, strong, excellent, rich, beautiful, and high-quality" modern socialist strong capital city, contributing even more Yinfeng strength to this endeavor.
The team successfully developed the CryoSIM platform, an intelligent microfluidics and deep learning-integrated system. This platform deeply integrates core technologies of deep learning and microfluidics to enable high-throughput, high-precision automated analysis of oocyte membrane permeability. It provides a novel technological tool for optimizing and advancing the clinical translation of oocyte cryopreservation techniques. Additionally, it offers an innovative practical paradigm for the application of artificial intelligence in low-temperature biomedicine and reproductive medicine.
Public Welfare Partnership: A Special Letter from the Jinan Red Cross
On the afternoon of January 30, 2026, the Jinan Red Cross presented a letter of special significance to the Shandong Yinfeng Life Science Public Welfare Foundation (hereinafter referred to as the Yinfeng Foundation).
World’s First Achievement Highlights Brand Leadership
In the future, Yinfeng Life Science Research Institute will continue to uphold its mission of "Dedicated to Medical Technology, Safeguarding Human Health." It will empower brand building with more original and pioneering scientific and technological achievements, contributing wisdom and strength to Shandong's goal of building a national regional innovation hub and promoting Chinese brands on the global stage.
Global First Ovarian Tissue Dual Activation Technology Debuts at 2025 Jinan Achievements Conference
Currently, the ovarian tissue dual activation technology has been successfully applied in clinical practice at Beijing University of Chinese Medicine Shenzhen (Longgang) Hospital, having treated over 400 patients with a treatment success rate of 70%. Over the next three years, Shandong Yinfeng Life Science Research Institute plans to use Jinan as a center to gradually expand the transformation and application of this technological achievement nationwide.